Advertisement

Topics

Immune Network Research Limited Company Profile

10:01 EDT 23rd July 2018 | BioPortfolio

Profile:A Vancouver, BC - based company, Immune Network Research Ltd. identifies outstanding commercial opportunities for new drug treatments, and takes them closer to market through rapid completion of critical milestones. Completion of these milestones is followed by licensing, alliances or spin-offs in order to create maximum return on investment for our shareholders.



Strategy:

Immune Network Research Ltd. has established a multi-disciplinary network of world class pharmacology experts in order to carefully select candidate drugs and technology.

Each prospective candidate opportunity will have an underlying foundation of strong science, protectable intellectual property, and a clearly identifiable commercial niche.

With rapid return on investment as the underlying basis of the strategy, the acquisition of rights, the addition of value, and the rapid divestiture through licenses, alliances or spin-offs will create a wide technology portfolio targeting important diseases, including Alzheimer's disease, Asthma, and AIDS.

Immune Network Research Ltd. will differentiate itself from other biotech companies by earning a strong reputation for successful commercialization of drugs aimed at these and other mainstream diseases.



Technological and Scientific Network:

Our extensive Network of Experts communicate and exchange information using the latest advanced business tools. The core group of the Company's Network includes pharmacology experts Drs. Brian Conway, Michael Grant, Sultan Karim, Heinz Köhler, Clive Page, and Michael Walker. Each of these experts provides a fundamental contribution to the Network.



Current Portfolio:

Our strategy allows for continuous project portfolio expansion and diversification. We believe this reduces risk for shareholders. Currently, we are developing products in three therapeutic areas:



Alzheimer's Disease: Immune Network Research Ltd. has acquired rights to a patent for the use of a group of compounds, based on an existing drug approved for another disease, in the treatment of Alzheimer's disease. The company anticipates that the next milestone for this project will be Phase II clinical trials.



Asthma: Immune Network Research Ltd., along with its joint venture partner Bridge Pharma, is carrying out research on a group of novel, non-steroidal, disease modifying agents for the treatment of asthma. The next milestone for this project will be the completion of laboratory studies on this group of compounds and selection of a clinical candidate



AIDS: Immune Network Research Ltd. has recently reacquired a 100% in this project involving a monoclonal antibody (1F7) which may represent a unique advancement in the treatment of AIDS. The company's former joint venture partner, ImmPheron, has completed pre-clinical research on the 1F7 antibody. This novel approach for treating HIV infection is aimed at resetting the body's immune system to continue to fight the AIDS virus even as it mutates. Immune Network is currently preparing a regulatory package for clinical trial approval.

Location

3650 Wesbrook Mall
Vancouver
British Columbia
V6S 2L2
Canada

Contact

Phone: 604 222 5541
Fax: 604 222 5542
Email: info@immunenetwork.com


News Articles [1293 Associated News Articles listed on BioPortfolio]

Research with made-in-Canada molecule targets fungal infections worldwide

(Canadian Glycomics Network) People whose immune systems are compromised from illnesses such as cancer can also fall victim to infections caused by fungal pathogens, which have become a major. GlycoNe...

Weill Cornell Medicine Joins TriNetX Health Research Network

TriNetX has announced that Weill Cornell Medicine has joined the TriNetX global health research network. Weill Cornell Medicine is a comprehensive, integrated academic healthcare delivery systems, an...

Review discusses complexity of immune-suppressive mechanisms in tumor milieu of cancers

Cancers control immune systems and evade immune detection using mediators consisting of immune checkpoint molecules and cellular systems associated with immune suppression.

Better Social Support Network Protects Black Men Against HIV

WEDNESDAY, May 23, 2018 -- A better social support network may help protect black men who have sex with men (BMSM) against HIV acquisition, according to a study published in the June issue of the Jour...

Network Viral Load: A Critical Metric for HIV Elimination

Network viral load, a new metric for measuring HIV risk, could play an important role in the development of HIV prevention interventions. JAIDS: Journal of Acquired Immune Deficiency Syndromes

Innovative collaborative research network to be led by Wake Forest, with AFAR

(American Federation for Aging Research) The National Institute on Aging (NIA) at NIH has awarded funds, expected to total $2.5 million over three years, to the Wake Forest School of Medicine, with a ...

‘Silenced’ immune cells can be activated to fight diseases

A research team at Garvan Institute of Medical Research in Australia has discovered that certain cells in the immune system...Read More... The post ‘Silenced’ immune cells can be activated to figh...

Aging immune system linked to cancer – BBC News

BBC NewsAging immune system linked to cancerBBC NewsThe key to preventing age-related cancers may lie in the body's own immune system, new research suggests. Scientists at the University of Dundee dis...

PubMed Articles [3973 Associated PubMed Articles listed on BioPortfolio]

Immune Signaling Networks: Sources of Robustness and Constrained Evolvability during Coevolution.

Defense against infection incurs costs as well as benefits that are expected to shape the evolution of optimal defense strategies. In particular, many theoretical studies have investigated contexts fa...

Research consortium Neuroimmunology and pain in the research network musculoskeletal diseases.

The research consortium Neuroimmunology and Pain (Neuroimpa) explores the importance of the relationships between the immune system and the nervous system in musculoskeletal diseases for the generatio...

Dynamics of virus and immune response in multi-epitope network.

The host immune response can often efficiently suppress a virus infection, which may lead to selection for immune-resistant viral variants within the host. For example, during HIV infection, an array ...

Sino-Austrian High-Tech Acupuncture Network: Annual Report 2017.

The Sino-Austrian High-Tech Acupuncture Research Network was founded in 2005 and has been growing ever since. The network comprises many partners from China and is highly involved in research and educ...

Engaging Latina breast cancer survivors in research: building a social network research registry.

Disparities persist in breast cancer outcomes between Latina survivors and non-Hispanic Whites. Identifying methods to ensure that Latinas participate in and benefit from translational behavioral medi...

Clinical Trials [4703 Associated Clinical Trials listed on BioPortfolio]

Participation in a Research Registry for Immune Disorders

Background: - People with primary immune deficiency diseases (PIDD) have weak immune systems. This makes it hard for their bodies to fight infection. The Immune Deficiency Foundation has ...

French Clinical Datbase of Melanoma Patients (RIC-Mel)

With a high incidence, low survival rates and limiter availability of effective treatment, melanoma is one of the research priorities for health authorities. Optimizing the development of ...

COPD Patient-Powered Research Network

The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to share thei...

Assessing Community Cancer Care After Insurance ExpanSionS

This innovative and timely study will measure the impact of Affordable Care Act (ACA) Medicaid expansions on cancer screenings and preventive services. To assess this natural policy experi...

Blood and Marrow Transplant Clinical Research Network

The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.

Companies [2225 Associated Companies listed on BioPortfolio]

Immune Network Research Limited

Profile:A Vancouver, BC - based company, Immune Network Research Ltd. identifies outstanding commercial opportunities for new drug treatments, and takes them closer to market through rapid completion ...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

BC Proteomics Network

The BC Proteomics Network (BCPN) is a growing network of researchers and informatics professionals from universities, research institutions and industry throughout British Columbia.  Formed in ...

iBridge Network

The iBridge(SM) Network is an innovation catalyst with a vibrant, online community enabling universities, companies and entrepreneurs to connect, collaborate and license tomorrow's research, products ...

National Institute for Health Research, Clinical Research Network

The Clinical Research Network is part of the National Institute for Health Research - the research arm of the National Health Service in England. The Clinical Research Network pro...

More Information about "Immune Network Research Limited" on BioPortfolio

We have published hundreds of Immune Network Research Limited news stories on BioPortfolio along with dozens of Immune Network Research Limited Clinical Trials and PubMed Articles about Immune Network Research Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immune Network Research Limited Companies in our database. You can also find out about relevant Immune Network Research Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record